Polycystic Kidney Disease Global Clinical Trials Review, H1, 2018

1
Growing Landscape Of The Global Clinical Trials
For The Polycystic Kidney Disease Market Outlook
Ken Research
2

• SUMMARY
• Global Data's clinical trial report, Polycystic
  Kidney Disease Global Clinical Trials Review, H1,
  2018 provides an overview of Polycystic Kidney
  Disease clinical trials scenario. This report
  provides top line data relating to the clinical
  trials on Polycystic Kidney Disease. Report
  includes an overview of trial numbers and their
  average enrollment in top countries conducted
  across the globe.
• The report offers coverage of disease clinical
  trials by region, country (G7 E7), phase, trial
  status, end points status and sponsor type.
  Report also provides prominent drugs for
  in-progress trials (based on number of ongoing
  trials).
•  
• The report enhances the decision making
  capabilities and helps to create an effective
  counter strategies to gain competitive advantage.
•  
• Note Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated disease.

3

• POLYCYSTIC KIDNEY
  DISEASE
• According to the report analysis, Polycystic
  Kidney Disease Global Clinical Trials Review, H1,
  2018 some of the major companies and healthcare
  organizations which are operating in this market
  with more efficiency includes otsuka holdings co
  ltd, pfizer inc,ipsen sa kadmon corpllc, novartis
  ag, merck co inc, iqvia holdings inc, davita
  inc, daiichi sankyo co ltd, c. H. Boehringersohn
  ag co kg, glaxosmithkline, sanofi, eli lilly
  and company, johnson johnson, bristol-myers
  squibb company, abbott laboratries, hoffmann-la
  roche ltd., celegene corporation, bayer ag, eisai
  inc.
• European organization for research and treatment
  of cancer, dana-farber cancer institute, case
  comprehensive cancer center, mayo clinic, duke
  university, ohio state university, university of
  pennsylvania and others. Moreover, for the better
  treatment of polycystic kidney disease more and
  more laboratories are established with more
  advance instrument for performing tests, related
  to the treatment of this disease.

4

• POLYCYSTIC
  KIDNEY DISEASE
• Polycystic kidney disease is a genetic kidney
  disease which means that it is cause by a problem
  with the abnormal genes which produce a specific
  abnormal protein which has an adverse effect on
  tubule development. Polycystic kidney disease
  which is also known as polycystic kidney
  syndrome.
• Polycystic kidney disease causes cysts to
  produce inside the kidneys whereas, these cysts
  make the kidneys much bigger than that of their
  normal size and can damage the tissue. Moreover,
  polycystic kidney disease is a of chronic kidney
  disease that decrease the functions of kidney and
  may result to kidney failure or end-stage renal
  disease.
• Additionally, with more advancement in the
  technology, upgradation in the old processing
  unit and establishment of new healthcare
  organization will lead to the significant growth
  in the coming years with more efficiency in the
  treatment.

5

• POLYCYSTIC KIDNEY DISEASE
• Geographically, the with high prevalence of the
  disease the market has been spread across the
  globe which majorly includes Asia-pacific region,
  Europe, North America, middle east and Africa,
  central and south America. Moreover the symptoms
  of polycystic kidney disease symptoms includes
  high blood pressure, back or side pain, headache,
  blood in urine, kidney failure and frequent
  urination.
• As the symptoms are more critical, the treatment
  or prevention which includes antihypertensive
  drugs and diuretics of this disease results to
  significant growth. In addition, increase in the
  research and development, high prevalence of
  disease, growing more opportunities from the
  funding of the new entrants are driving the
  growth in the vaccines market.
• Therefore, with the new entrants of the key
  players in the market it is expected that in
  future, the market will grow more significantly
  in the coming years.

6

• Browse Full Market Report
• Polycystic Kidney Disease Global Clinical Trials
  Review, H1, 2018
• Related reports
• Polycystic Kidney Disease-Pipeline Review, H1
  2017
• Polycystic Kidney Disease Global Clinical Trials
  Review, H2, 2016

7
About ken research

• Ken Research provides bespoke industry
  intelligence, equity research reports and
  business consulting services on gamut of sectors
  across the globe. We use advanced information
  management tools, sophisticated analytical
  systems and methodologies to help our clients
  with crucial industry information for decision
  making.
• As a leading Online Market Research Report
  Seller, Ken Research act as a platform for
  accessing statistics, forecast, business
  insights, Ideas, concepts and much more.

8

• Contact Us
• Ken Research
• Ankur Gupta, Head Marketing Communications
• sales_at_kenresearch.com
• 91-9015378249

9
(No Transcript)